1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Women Infertility Global Clinical Trials Review, H2, 2014

Women Infertility Global Clinical Trials Review, H2, 2014

  • November 2014
  • -
  • Global Data
  • -
  • 118 pages

Women Infertility Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Women Infertility Global Clinical Trials Review, H2, 2014" provides data on the Women Infertility clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Women Infertility. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Women Infertility. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Women Infertility Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 6
Women Infertility 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Women Infertility to Women's Health Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Women Infertility to Women's Health Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Women Infertility 25
Subjects Recruited Over a Period of Time 33
Clinical Trials by Sponsor Type 34
Prominent Sponsors 35
Top Companies Participating in Women Infertility Therapeutics Clinical Trials 36
Prominent Drugs 37
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
E. Merck KG 38
Clinical Trial Overview of E. Merck KG 38
Ferring International Center S.A. 43
Clinical Trial Overview of Ferring International Center S.A. 43
Merck and Co., Inc. 46
Clinical Trial Overview of Merck and Co., Inc. 46
AbbVie Inc. 49
Clinical Trial Overview of AbbVie Inc. 49
Bayer AG 51
Clinical Trial Overview of Bayer AG 51
IBSA Institut Biochimique SA 52
Clinical Trial Overview of IBSA Institut Biochimique SA 52
Repros Therapeutics Inc. 53
Clinical Trial Overview of Repros Therapeutics Inc. 53
Neurocrine Biosciences, Inc. 54
Clinical Trial Overview of Neurocrine Biosciences, Inc. 54
Pfizer Inc. 55
Clinical Trial Overview of Pfizer Inc. 55
Boston IVF 56
Clinical Trial Overview of Boston IVF 56
Clinical Trial Overview of Top Institutes / Government 57
Tehran University of Medical Sciences 57
Clinical Trial Overview of Tehran University of Medical Sciences 57
Eunice Kennedy Shriver National Institute of Child Health and Human Development 60
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 60
Universitair Ziekenhuis Brussel 62
Clinical Trial Overview of Universitair Ziekenhuis Brussel 62
Yazd Research and Clinical Center for Infertility 64
Clinical Trial Overview of Yazd Research and Clinical Center for Infertility 64
Instituto Valenciano de Infertilidad 66
Clinical Trial Overview of Instituto Valenciano de Infertilidad 66
University Magna Graecia 68
Clinical Trial Overview of University Magna Graecia 68
Shiraz University of Medical Sciences 69
Clinical Trial Overview of Shiraz University of Medical Sciences 69
Tabriz University of Medical Sciences 71
Clinical Trial Overview of Tabriz University of Medical Sciences 71
University of Virginia 72
Clinical Trial Overview of University of Virginia 72
Babol University of Medical Sciences 73
Clinical Trial Overview of Babol University of Medical Sciences 73
Five Key Clinical Profiles 74
Appendix 116
Abbreviations 116
Definitions 116
Research Methodology 117
Secondary Research 117
About GlobalData 118
Contact Us 118
Disclaimer 118
Source 118

List of Tables
Women Infertility Therapeutics, Global, Clinical Trials by Region, 2014* 7
Women Infertility Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Women Infertility Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Women Infertility Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Women Infertility Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Women Infertility Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Women Infertility Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Women Infertility Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Women Infertility to Women's Health Clinical Trials, G7 Countries (%), 2014* 15
Women Infertility Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Women Infertility Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Women Infertility to Women's Health Clinical Trials, E7 Countries (%), 2014* 18
Women Infertility Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Women Infertility Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Women Infertility Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Women Infertility Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Women Infertility Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Women Infertility Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Women Infertility Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Women Infertility Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Women Infertility Therapeutics, Global, Terminated Clinical Trials, 2014* 28
Women Infertility Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 33
Women Infertility Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 34
Women Infertility Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 35
Women Infertility Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 36
Women Infertility Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 37
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2014* 38
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2014* 43
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 46
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014* 49
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 51
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by IBSA Institut Biochimique SA, 2014* 52
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Repros Therapeutics Inc., 2014* 53
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurocrine Biosciences, Inc., 2014* 54
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 55
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston IVF, 2014* 56
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 57
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 60
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Universitair Ziekenhuis Brussel, 2014* 62
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Yazd Research and Clinical Center for Infertility, 2014* 64
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto Valenciano de Infertilidad, 2014* 66
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by University Magna Graecia, 2014* 68
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2014* 69
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University of Medical Sciences, 2014* 71
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2014* 72
Women Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Babol University of Medical Sciences, 2014* 73

List of Figures
Women Infertility Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Women Infertility Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Women Infertility Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Women Infertility Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Women Infertility Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Women Infertility Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Women Infertility Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Women Infertility Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Women Infertility to Women's Health Clinical Trials, G7 Countries (%), 2014* 15
Women Infertility Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Women Infertility Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Women Infertility to Women's Health Clinical Trials, E7 Countries (%), 2014* 18
Women Infertility Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Women Infertility Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Women Infertility Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Women Infertility Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Women Infertility Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Women Infertility Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Women Infertility Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 33
Women Infertility Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 34
Women Infertility Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 35
Women Infertility Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 36
Women Infertility Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 37
GlobalData Methodology 117

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Europe Tumor Marker Testing in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppl

2016 Europe Tumor Marker Testing in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppl

  • $ 34500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 925 pages and 366 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Insulin Market and Diabetes Statistics in the US

  • February 2017
    8 pages
  • Insulin  

    Antidiabetics  

    Diabetes  

  • United States  

View report >

Hormone and Therapy Market in Pakistan and the US

  • February 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

Hormone Market in the US

  • February 2017
    9 pages
  • Hormone  

  • United States  

View report >

Related Market Segments :

Hormone
Therapy
Clinical Trial

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.